In summary, the concurrent treatment with an inhibitor of miR-20a-5p and si-PTEN significantly restored the migration capability of CRC cells that had been suppressed by the miR-20a-5p inhibitor. This evidence concerns the gene PTEN and colorectal carcinoma.